XIAP and Jacobsen syndrome: In total, 11/39 patients (28.2%) had a confirmed molecular diagnosis, including known IEIs such as Jacobsen syndrome, 22q11.2 deletion syndrome, and XLP2, as well as syndromes not yet officially recognized as IEIs (e.g., MYT1L, Down syndrome).